Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Review

Nutrition in calcium nephrolithiasis

Authors: Elena Dogliotti, Giuseppe Vezzoli, Antonio Nouvenne, Tiziana Meschi, Annalisa Terranegra, Alessandra Mingione, Caterina Brasacchio, Benedetta Raspini, Daniele Cusi, Laura Soldati

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

Idiopathic calcium nephrolithiasis is a multifactorial disease with a complex pathogenesis due to genetic and environmental factors. The importance of social and health effects of nephrolithiasis is further highlighted by the strong tendency to relapse of the disease. Long-term prospective studies show a peak of disease recurrence within 2–3 years since onset, 40-50% of patients have a recurrence after 5 years and more than 50-60% after 10 years. International nutritional studies demonstrated that nutritional habits are relevant in therapy and prevention approaches of nephrolithiasis. Water, right intake of calcium, low intake of sodium, high levels of urinary citrate are certainly important for the primary and secondary prevention of nephrolithiasis.
In this review is discussed how the correction of nutritional mistakes can reduce the incidence of recurrent nephrolithiasis.
Appendix
Available only for authorised users
Literature
1.
Racioppi M, Palermo G, D'Addessi A, Pinto F, Sacco E, D'Agostino D, Vittori M, Bassi PF: Hot topics in urological health economics. A mini review. Arch Ital Urol Androl. 2012, 84 (2): 47-52.PubMed
2.
Hughes P: The CARI guidelines. Kidney stones epidemiology. Caring for Australians with renal impairment (CARI). Nephrology (Carlton). 2007, 12 (Suppl 1): S26-S30.CrossRef
3.
4.
Soucie JM: Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994, 46 (3): 893-899. 10.1038/ki.1994.347.CrossRefPubMed
5.
Goldfarb DS: Increasing prevalence of kidney stones in the United States. Kidney Int. 2003, 63: 1951-1952. 10.1046/j.1523-1755.2003.00942.x.CrossRefPubMed
6.
Borghi L: Epidemiological aspects of nefrolithiasis. G It Met Min. 1989, 3 (2): 71-79.
7.
Evan P: Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. 2010, 25 (5): 831-841. 10.1007/s00467-009-1116-y.PubMedCentralCrossRefPubMed
8.
Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E: Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol. 2000, 37: 23-25. 10.1159/000020094.CrossRefPubMed
9.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993, 328: 833-838. 10.1056/NEJM199303253281203.CrossRefPubMed
10.
Asplin JR, Coe FL, Favus MJ: Nefrolitiasis, in Harrison - principles of internal medicine 16 a ed. McGraw-Hill. 2005, 268: 1927-1932.
11.
Thomas M: The CARI guidelines. Clinical diagnosis of kidney stones. Caring for Australians with renal impairment (CARI). Nephrology (Carlton). 2007, 12 (Suppl 1): S1-S3.CrossRef
12.
Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R, Matlaga BR: The association of increasing body mass index and kidney stone disease. J Urol. 2010, 183: 571-575. 10.1016/j.juro.2009.09.085.PubMedCentralCrossRefPubMed
13.
Yi JJ, Yi LJ, Xiang GZ, Qing WW, Yong LJ, Jiang LJ, Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R, Matlaga BR: Re: the association of increasing body mass index and kidney stone disease. J Urol. 2010, 183: 571-575. 10.1016/j.juro.2009.09.085. J Urol. 2011 May; 185(5): 1984CrossRef
14.
Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997, 126: 497-504. 10.7326/0003-4819-126-7-199704010-00001.CrossRefPubMed
15.
Curhan GC, Willett WC, Knight EL, Stampfer MJ: Dietary factors and the risk of incidence kidney stones in younger women. Arch Intern Med. 2004, 164: 885-891. 10.1001/archinte.164.8.885.CrossRefPubMed
16.
Daudon M, Bounxouei B, Santa Cruz F, Leite Da Silva S, Diouf B, Angwafoo FF, Talati J, Desrez G: Composition of renal stones currently observed in non –industrialized countries. [Article in French] Prog Urol. 2004, 14 (6): 1151-1161.PubMed
17.
Scales CD, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA, Preminger GM: Changing gender prevalence of stone disease. J Urol. 2007, 177 (3): 979-982. 10.1016/j.juro.2006.10.069.CrossRefPubMed
18.
Sakhaee K, Maalouf NM, Sinnott B: Kidney stones 2012: pathogenesis, Diagnosis and Management. J Clin Endocrinol Metab. 2012, 97: 1847-1860. 10.1210/jc.2011-3492.PubMedCentralCrossRefPubMed
19.
Miller NL: Pathogenesis of renal calculi. Urol Clin North Am. 2007, 34 (3): 295-313. 10.1016/j.ucl.2007.05.007.CrossRefPubMed
20.
Phillips CM: Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients. 2013, 5 (1): 32-57. 10.3390/nu5010032.PubMedCentralCrossRefPubMed
21.
Kant AK, Graubard BI: Secular trends in patterns of self-reported food consumption of adult Americans: NHANES 1971–1975 to NHANES 1999–2002. Am J Clin Nutr. 2006, 84 (5): 1215-1223.PubMedCentralPubMed
22.
Jolliffe D: Extent of overweight among US children and adolescents from 1971 to 2000. Int J Obes Relat Metab Disord. 2004, 28 (1): 4-9. 10.1038/sj.ijo.0802421.CrossRefPubMed
23.
Vezzoli G, Terranegra A, Arcidiacono T, Soldati L: Genetics and calcium nephrolithiasis. Kidney Int. 2011, 80 (6): 587-593. 10.1038/ki.2010.430.CrossRefPubMed
24.
25.
Taylor EN, Stampfer MJ, Curhan GC: Dietary factors and the risk of incident kidney stones in men: new insight after 14 years of follow –up. J Am Soc Nephrol. 2004, 15: 3225-3232. 10.1097/01.ASN.0000146012.44570.20.CrossRefPubMed
26.
Kairaitis L: The CARI guidelines. Kidney stones: prevention of recurrent calcium nephrolithiasis. Caring for Australians with renal impairment (CARI). Nephrology (Carlton). 2007, 12 (Suppl 1): S11-S20.CrossRef
27.
Frank M, De Vries A, Tikva P: Prevention of urolithiasis. Arch Environ Health. 1966, 13: 625-630. 10.1080/00039896.1966.10664630.CrossRefPubMed
28.
Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A: Urinary volume, water recurrences in idiopatic calcium nephrolitiasis: a 5 year randomized prospective study. J Urol. 1996, 155: 839-884. 10.1016/S0022-5347(01)66321-3.CrossRefPubMed
29.
Nouvenne A, Meschi T, Guerra A, Allegri F, Prati B, Borghi L: Dietary treatment of nephrolithiasis. Clin cases Miner Bone Metab. 2008, 5 (2): 135-141.PubMedCentralPubMed
30.
Meschi T, Nouvenne A, Borghi L: Lifestyle recommendations to reduce the risk of kidney stones. Urol Clin North Am. 2011, 38 (3): 313-320. 10.1016/j.ucl.2011.04.002.CrossRefPubMed
31.
Jeong BC, Kim BS, Kim JI: Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol. 2006, 20: 356-361. 10.1089/end.2006.20.356.CrossRefPubMed
32.
Johri N, Cooper B, Robertson W: An update and practical guide to renal stone management. Nephron Clin Pract. 2010, 116: 159-171. 10.1159/000317196.CrossRef
33.
Kessler T, Jansen B, Hesse A: Effect of blackcurrant-, cranberry-, and plum juice consumption on risk factors associated with kidney stones formation. Eur J Clin Nutr. 2002, 56 (10): 1020-1023. 10.1038/sj.ejcn.1601442.CrossRefPubMed
34.
Jepson RG, Williams G, Craig JC: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012, 10: CD001321-PubMed
35.
Savage GP, Charrier MJ, Vanhanen L: Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Eur J Clin Nutr. 2003, 57 (3): 415-419. 10.1038/sj.ejcn.1601572.CrossRefPubMed
36.
Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ: Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol. 1996, 143 (3): 240-247. 10.1093/oxfordjournals.aje.a008734.CrossRefPubMed
37.
Fink HA, Akornor JW, Garimella PS: Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009, 56: 72-80. 10.1016/j.eururo.2009.03.031.PubMedCentralCrossRefPubMed
38.
Rodgers A: Effect of cola consumption on urinary biochemical and physicochemical risk factors associated with calcium oxalate urolithiasis. Urol Res. 1999, 27: 77-81. 10.1007/s002400050092.CrossRefPubMed
39.
Lemann J, Adams ND, Gray RW: Urinary calcium excretion in human beings. N Engl J Med. 1979, 30: 535-541.
40.
Coe FL, Parks JH, Asplin JR: The pathogenesis and treatment of kidney stones. N Engl J Med. 1992, 327: 1141-1152. 10.1056/NEJM199210153271607.CrossRefPubMed
41.
Lehmann J, Pleuss JA, Gray RW: Increased dietary calcium intakes reduce urinary oxalate excretion in healthy adults. Urolithiasis. Edited by: Walzer VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG. 1989, New York and London: Plenum Press, 435-438.CrossRef
42.
Borghi L, Schianchi T, Meschi T: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002, 346: 77-84. 10.1056/NEJMoa010369.CrossRefPubMed
43.
Massey LK, Whiting SJ: Dietary salt, urinary calcium and kidney stone risk. Nutr Rev. 1995, 53: 131-134.CrossRefPubMed
44.
Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L: Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010, 91: 565-570. 10.3945/ajcn.2009.28614.CrossRefPubMed
45.
Colussi G, Surian M, De Ferrari ME, Pontoriero G, Rombolà G, Brando B, Malberti F, Cosci P, Aroldi A, Castelnovo C: Relationship between sodium intake, proximal tubular function and calcium excretion in normal subjects and in idiopathic hypercalciuria. Eur Proc Eur Dial Transplant Assoc. 1983, 20: 455-459.PubMed
46.
Meschi T, Nouvenne A, Ticinesi A, Prati B, Guerra A, Allegri F, Pigna L, Soldati L: Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med. 2012, 10: 63-70. 10.1186/1479-5876-10-63.PubMedCentralCrossRefPubMed
47.
Maalouf NM, Moe OW, Adams-Huet B, Sakhaee K: Hypercalciuria associated with high dietary protein intake is Not Due to acid load. J Clin Endocrinol Metab. 2011, 96: 3733-3740. 10.1210/jc.2011-1531.PubMedCentralCrossRefPubMed
48.
Caudarella R, Vescini F: Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital Urol Androl. 2009, 81 (3): 182-187.PubMed
49.
He Y, Chen X, Yu Z, Wu D, Lv Y, Shi S, Zhu H: Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis. J Nephrol. 2004, 17 (1): 34-42.PubMed
50.
Okamoto N, Aruga S, Matsuzaki S, Takahashi S, Matsushita K, Kitamura T: Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls. Int J Urol. 2007, 14 (4): 344-349. 10.1111/j.1442-2042.2007.01554.x.CrossRefPubMed
51.
Strohmaier WL, Seilnacht J, Schubert G: Urinary stone formers with hypocitraturia and ‘normal’ urinary pH are at high risk for recurrence. Urol Int. 2012, 88 (3): 294-297. 10.1159/000335441.CrossRefPubMed
52.
Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CYC: Effect of low-carbohydrate high protein diets on acid–base balance, stone forming propensity, and calcium metabolism. Am J Kidney Dis. 2002, 40: 265-274. 10.1053/ajkd.2002.34504.CrossRefPubMed
53.
54.
Taylor EN, Fung TT, Curhan GC: DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009, 20 (10): 2253-2259. 10.1681/ASN.2009030276.PubMedCentralCrossRefPubMed
Metadata
Title
Nutrition in calcium nephrolithiasis
Authors
Elena Dogliotti
Giuseppe Vezzoli
Antonio Nouvenne
Tiziana Meschi
Annalisa Terranegra
Alessandra Mingione
Caterina Brasacchio
Benedetta Raspini
Daniele Cusi
Laura Soldati
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-109

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue

Research

Effects of age on noninvasive assessments of vascular function in nonhuman primates: implications for translational drug discovery

Research

Notch signaling activation contributes to cardioprotection provided by ischemic preconditioning and postconditioning

Research

The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere

Research

Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC

Research

Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol induced myocardial necrosis: a new therapeutic implication

Research

Mild therapeutic hypothermia is superior to controlled normothermia for the maintenance of blood pressure and cerebral oxygenation, prevention of organ damage and suppression of oxidative stress after cardiac arrest in a porcine model
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits